MedTrace Logo

Transform: Teaching, Technology, and Teams

NCT05572814 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2022-10-10

No results posted yet for this study

Summary

This initiative supports a quality improvement effort evaluating the use of strategies (including technology-based decision support, referral to a virtual GDMT team, and general educational tools/resources for clinicians and patients) to improve use of guideline-directed therapeutics known to lower cardiovascular (CV) events among patients with cardiovascular diseases of heart failure, atrial fibrillation and type 2 diabetes (T2D)/ASCVD with a specific focus on underserved populations and those with a history of health care disparities.

Conditions

Interventions

BEHAVIORAL

Decision Support

Prompts will be provided to clinicians signaling gaps in guideline-directed care

BEHAVIORAL

Referral

Patients will be referred to an interdisciplinary, expert guideline-directed medical therapy team

Sponsors & Collaborators

Principal Investigators

  • James MD Januzzi, MD · Massachusetts General Hospital

  • Ankeet S Bhatt, MD · Kaiser Permanente

  • Andrew Oseran, MD · Massachusetts General Hospital

  • Megan Welch, MD · Massachusetts General Hospital

  • Jagmeet Singh, MD · Massachusetts General Hospital

  • Muthiah Vadduganathan, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572814 on ClinicalTrials.gov